Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NOA-07: Radiochemotherapy in Adult Medulloblastoma
NCT01614132Phase 2Completed
- Sponsor
- University of Regensburg
- Start
- Jan 2009
- Primary completion
- Oct 2018
- Modality
- DNA Intercalators/Alkylators, Covalent Small Molecules, Classical Binding Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of vincristine, cisplatin and lomustine in medulloblastoma, sponsored by University of Regensburg. Primary endpoint: Feasibility of the adjuvant chemotherapy at 1 year. Started Jan 2009; status: completed.
02
Drugs
vincristinecisplatinlomustine
03
Conditions
medulloblastoma
Beyond the preview
Go deeper on NCT01614132.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01614132.